Waterbury, Connecticut 06708
203-419-4420 http://www.chasemr.com Medical_research@chasemr.com
Chase Medical Research, LLC, formerly known as the Clinical Research Department of Phoenix Internal Medicine Associates, LLC. is led by Joseph Soufer, MD, who specializes in Internal Medicine with a sub-specialty of Endocrinology. Dr. Soufer has practiced Internal Medicine in the Waterbury community for the past 25 years and serves as Medical Director of the clinical research department since the year 2000.
Chase Medical Research, LLC is affiliated with area specialists in Neurology, Psychology, Rheumatology, Gastroenterology and Obstetrics and Gynecology. Studies have been conducted in the therapeutic areas of Women's Health, Endocrinology, Cardiovascular, Central Nervous System, Rheumatology, Men's Health and Metabolic Disorders. Chase Medical Research, LLC consists of partnering physicians from the following specialty groups: Phoenix Internal Medicine Associates, LLC, Digestive Disease Center of Connecticut and Leonard I.Goldstein, PsyD of the Connecticut Resource Group. All participating physicians are Board Certified in their specialty areas of medicine.
Chase Medical Research, LLC consists of 3 FTE Clinical Research Coordinators, 1 FTE Manager of Administrative Services, 1 FTE Patient Recruitment Coordinator, 1 FTE Document Specialist/Laboratory Assistant and 1 FTE Office Assistant. All research is conducted in our Waterbury facility. We offer a comfortable, efficient and a private workplace for CRA's with access to phone, fax and modem. Hotels are conveniently located nearby.
Medical Director: Joseph Soufer, MD
Physicians (Principal/Sub-Investigators):
-
Joseph Soufer, MD
Board Certified in Internal Medicine
Specializing in Endocrinology
Certified In Bone Densitometry -
Leonardi Koliani, MD
Board Certified in Internal Medicine
Medical Director and/or Attending Physician at approximately 12 local Convalescent Homes/Extended Care Facilities -
Arthur L. Lebowitz, MD
Board Certified in Internal Medicine
Certified In Bone Densitometry -
Joseph DeLuca, MD
Board Certified in Internal Medicine -
Peter G. Levinson, MD
Board Certified in Internal Medicine -
Stephen R. Rubenstein, MD, FACP
Board Certified in Internal Medicine
Diane Rabideau, RN, IV-C, CRC
Director of Clinical Operations
4 years of Clinical Research Experience
Staci M. Berardi, MA, CRC
Study Coordinator
2 years of Clinical Research Experience
Siobhan Reilly, CRC
Study Coordinator
2½ years of Clinical Research Experience
Cheryl J. Nickles
Patient Recruitment Coordinator
3 years of Clinical Research Experience
Deborah Pillis
Document Specialist/Laboratory Assistant
3 years of Clinical Research Experience
Kimberly R. Vasquez
Manager of Administrative Services
3 years of Clinical Research Experience
Christine Ludovicy
Office Assistant
1 year of Clinical Research Experience
| Age Group: | |
| 18-30 | 20% |
| 31-50 | 30% |
| 51-70 | 25% |
| >70 | 25% |
Cardiology/Vascular Diseases
Endocrinology
Gastroenterology
Musculoskeletal
Nephrology/Urology
Neurology
Obstetrics/Gynecology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Chase Medical Research, LLC- offers outpatient research at present.
On-Site Equipment:
- Secure drug storage (locked, temperature-controlled cabinets)
- Secure record storage
- Sphygmomanometers
- ECG
- (3)-20 degree freezers
- Dedicated Refrigerator
- Full Laboratory Services
- Centrifuge
- Phlebotomy
- DEXA (Lunar)
- Work area for CRA'S
- Conference Room
- Crash Cart + CPR/AED certified staff
- Exam rooms
- PFT Spirometer
- Access to dry ice
- Access to Radiological Services
- Access to Hologic DEXA Services
Diane Rabideau, RN, IV-C, CRC
Director of Clinical Operations
Chase Medical Research, LLC
500 Chase Parkway - 3rd Floor
Waterbury, CT 06708
USA
203-419-4420
203-465-7924 (fax)
Medical_research@chasemr.com
www.chasemr.com
- A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Asimadoline in Subjects with Diarrhea-Predominant Irritable Bowel Syndrome.
- A Phase 3b Multicenter, Double-Blind, Randomized Withdrawal Efficacy and Safety Study of Pregabalin in the Treatment of Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy.
- A Randomized, Double-blind, Placebo-controlled, Parallel group, Dose ranging, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Irritable Bowel Syndrome with Diarrhea.
- A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Adaptive Design Phase 2 Study of Three Different Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo in Subjects with Mild to Moderate Probable Alzheimer's Disease.
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969
Updated: 12/31/1969